golimumab monoclonal antibody drug. targets tnf-alpha. indications for use include rheumatoid arthritis, psoriatic arthritis,

alpha ankylosing antibody arthritis biological biosimilar biotech biotechnology colitis disease drug factor golimumab immune immunoglobulin immunology immunosuppressive infusion inhibitor injection inn mab monoclonal necrosis nomenclature peptide protein psoriatic rheumatoid spondylitis tnf tnfa tumor ulcerative